Purity and Identity Are Not the Same

In peptide analytical reports, purity and identity are often listed near each other and sometimes treated as interchangeable. They are not. Each answers a different scientific question, and reviewing one without the other can leave important uncertainty unresolved.

This article explains the distinction in laboratory terms and why batch documentation should present both kinds of evidence in context. For research use only. Not for human consumption.

Two different questions

Identity asks: Is the principal component consistent with the intended peptide?

Evidence may include molecular mass, chromatographic retention relative to a reference, fragmentation pattern, composition data, or other orthogonal results.

Purity asks: What fraction of the detected chromatographic response is attributable to the principal component under a defined method?

Evidence is commonly an HPLC area-percent result, supported by the chromatogram, integration rules, and method conditions.

A sample can show a high purity percentage and still fail to confirm the intended identity. Conversely, a correctly identified peptide may contain measurable process- or degradation-related impurities.

Why the terms are not interchangeable

Calling a material “pure” does not prove chemical identity. Calling a material “identified” does not prove that related substances are negligible.

Common points of confusion:

• A dominant HPLC peak supports relative chromatographic abundance under that method. It does not, by itself, prove sequence or full molecular structure.
• A mass match supports molecular composition. It does not automatically quantify every impurity or establish chromatographic purity.
• Assay, content, water, counter-ion, and residual solvent results address still other questions and should not be folded into a single “purity” label without definition.

Clear reports name the attribute, the method, the specification, and the result separately. See How to Read a Peptide Certificate of Analysis for how those fields typically appear on a COA.

What HPLC can indicate

High-performance liquid chromatography separates components before detection. For peptide work, reversed-phase HPLC with UV detection is widely used to estimate chromatographic purity.

HPLC can indicate:

• relative area of the principal peak versus other included peaks
• retention behavior under a defined gradient and column
• presence of resolved impurities or degradation products
• method performance through system-suitability checks

HPLC does not automatically:

• prove absolute chemical identity from retention time alone
• detect every impurity (co-elution, weak detector response, or non-eluting species remain possible)
• convert peak area into mass fraction without response-factor considerations

For method-level detail, see HPLC Peptide Purity Testing Explained.

What mass spectrometry can contribute

Mass spectrometry measures ions by mass-to-charge ratio. For peptides, intact-mass and related LC-MS data are commonly used to support identity and to characterize modifications or impurities.

Mass spectrometry can contribute:

• confirmation that observed mass is consistent with the expected molecular composition
• detection of mass shifts associated with oxidation, truncation, adducts, or other variants
• association of chromatographic peaks with mass signals when LC-MS is used
• sequence-supporting information when tandem MS or peptide-mapping strategies are applied

Mass spectrometry does not automatically:

• distinguish all isobaric or stereochemical possibilities from intact mass alone
• provide a simple area-percent purity equivalent to HPLC UV without careful method definition
• replace chromatographic separation for impurity resolution in every case

For platform-level detail, see Mass Spectrometry for Peptide Identity. A side-by-side comparison of analytical roles is in HPLC vs. Mass Spectrometry: What Each Method Tells You.

Why multiple data points should be reviewed together

Orthogonal evidence reduces the risk of over-interpreting a single number.

A practical laboratory review often includes:

1. Identity evidence — mass, retention versus reference where used, and any sequence-supporting data
2. Purity evidence — chromatogram, peak table, method identification, and reported chromatographic purity
3. Supporting measurements — assay/content, water, residual solvents, or other specified tests when present
4. Method context — versioned method identifiers, system suitability, and laboratory identification
5. Batch linkage — lot or batch number matching the material, labels, and related records

Agreement across methods increases confidence. Disagreement is a signal to investigate method suitability, sample handling, integration decisions, or documentation completeness rather than to collapse everything into one headline percentage.

Lot and batch traceability

Analytical results are meaningful only when tied to a defined lot or batch. A purity or identity statement without batch linkage cannot be verified against the material in hand.

Reviewers should confirm that:

• the COA batch identifier matches the vial or container label
• test dates, report numbers, and revisions are present and consistent
• methods are identified at a level that supports reproducibility discussion
• superseded certificates are clearly marked when applicable

Traceability is part of scientific interpretation, not an administrative afterthought.

Frequently asked questions

Can a COA list both purity and identity?

Yes. Strong certificates present them as separate tests with methods, specifications, and results.

Does a 99% HPLC purity prove the correct peptide?

No. High chromatographic purity indicates relative peak area under the method. Identity requires separate supporting evidence.

Does a correct molecular weight prove the sample is pure?

No. Mass consistency supports identity-related questions. Impurity profile and chromatographic purity remain separate.

Why do laboratories report both HPLC and MS?

They address complementary questions: separation and relative abundance versus molecular mass and related characterization.

Key takeaways

• Purity and identity are different analytical attributes.
• HPLC commonly informs chromatographic purity and impurity resolution under a defined method.
• Mass spectrometry commonly informs molecular identity and mass-based characterization.
• Reviewing multiple results, methods, and lot identifiers together produces a more defensible laboratory interpretation than relying on a single headline value.

References

1. FDA. Analytical Procedures and Methods Validation for Drugs and Biologics: Guidance for Industry.
2. ICH Q2(R2). Validation of Analytical Procedures.
3. ICH M10. Bioanalytical Method Validation and Study Sample Analysis.

---

TSMS Labs educational disclaimer: For laboratory research and educational purposes only. Not for human consumption. This content is not medical, clinical, or regulatory advice.